The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116165555 11616555 5 F 20140303 20160725 20151009 20160801 EXP PHHY2014CA039580 SANDOZ 41.02 YR F Y 0.00000 20160801 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116165555 11616555 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 300 MG, BIW U 0 300 MG QOW
116165555 11616555 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0
116165555 11616555 3 PS HYDROXYZINE HYDROXYZINEHYDROXYZINE HYDROCHLORIDE 1 Unknown UNK U 81127
116165555 11616555 4 SS HYDROXYZINE HYDROXYZINEHYDROXYZINE HYDROCHLORIDE 1 U 81127
116165555 11616555 5 C CETIRIZINE CETIRIZINE HYDROCHLORIDE 1 Unknown UNK U 0
116165555 11616555 6 C TECTA PANTOPRAZOLE MAGNESIUM 1 Unknown UNK U 0
116165555 11616555 7 C NAPROXEN. NAPROXEN 1 Unknown UNK U 0
116165555 11616555 8 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 Unknown UNK U 0
116165555 11616555 9 C HYDROMORPHONE HYDROMORPHONE 1 Unknown UNK U 0
116165555 11616555 10 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown UNK U 0
116165555 11616555 11 C VENTOLIN ALBUTEROL SULFATE 1 Unknown UNK U 0
116165555 11616555 12 C PLAQUENIL HYDROXYCHLOROQUINE SULFATE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116165555 11616555 1 Chronic spontaneous urticaria
116165555 11616555 2 Asthma
116165555 11616555 3 Rubber sensitivity
116165555 11616555 4 Anaphylactic reaction
116165555 11616555 5 Product used for unknown indication
116165555 11616555 6 Product used for unknown indication
116165555 11616555 7 Product used for unknown indication
116165555 11616555 8 Product used for unknown indication
116165555 11616555 9 Product used for unknown indication
116165555 11616555 10 Product used for unknown indication
116165555 11616555 11 Product used for unknown indication
116165555 11616555 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
116165555 11616555 OT
116165555 11616555 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116165555 11616555 Anaphylactic reaction
116165555 11616555 Asthma
116165555 11616555 Blood immunoglobulin E increased
116165555 11616555 Blood potassium decreased
116165555 11616555 Blood pressure decreased
116165555 11616555 Cellulitis
116165555 11616555 Decreased activity
116165555 11616555 Decreased appetite
116165555 11616555 Disease progression
116165555 11616555 Drug hypersensitivity
116165555 11616555 Dysgeusia
116165555 11616555 Feeding disorder
116165555 11616555 Flushing
116165555 11616555 Food allergy
116165555 11616555 Hyperaesthesia
116165555 11616555 Malaise
116165555 11616555 Mast cell activation syndrome
116165555 11616555 Mechanical urticaria
116165555 11616555 Mouth ulceration
116165555 11616555 Multiple allergies
116165555 11616555 Oral pain
116165555 11616555 Rubber sensitivity
116165555 11616555 Smoke sensitivity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116165555 11616555 1 20130110 0
116165555 11616555 2 20150422 0